Building a Next-Gen Microfluidics Blood Lab for COVID Immunity Testing

Building a Next-Gen Microfluidics Blood Lab for COVID Immunity TestingПодробнее

Accelerating vaccine development using a next generation microfluidic CE platformПодробнее

Multiparameter Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 High Throughput SPR AssayПодробнее

Microfluidic, Nanoliter-scale Immunoassay for SARS-CoV-2 Serology Test, Vaccine and Drug DevelopmentПодробнее

A Lab-on-a-Chip for the Concurrent Electrochemical Detection of SARS-CoV-2 Nucleic Acids and...Подробнее

Antibody Discovery and Development Efforts Fueling the Future of Diagnostic TestingПодробнее

Researchers develop lab-on-a-chip tech for Covid testingПодробнее

Canadian COVID Treatment & Vaccine DevelopmentПодробнее

Edvotek MyLab: Simulating the COVID-19 Antibody TestПодробнее

Serology testing determines if you can build immunity to COVID-19, but there's a catchПодробнее

Antibody Testing: The Next Step in the Fight Against COVID-19Подробнее

Microchip Technology enabling Rapid Diagnostics and Surveillance of COVID-19Подробнее

Han Wei Hou: Microfluidics isolation of blood EVs for Vascular Risk Profiling in Type 2 DiabetesПодробнее

Solvent-free production methods for liposomes and lipid nanoparticlesПодробнее

Aniruddh Sarkar (Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech and Emory)Подробнее

Coronavirus Antibody Test and Immunity to COVID-19Подробнее

Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2Подробнее

Microfluidics for Clinical Diagnostics of COVID-19 and Other Infectious Diseases | Technical WebinarПодробнее

What is Antibody Testing for COVID -19? How It Works | MetropolisПодробнее

Актуальное